Live Attendee Prizes Throughout our live event, the RNS will be raffling off a variety of prizes. You must be present during the live event when the raffle is occuring to claim a prize. In addition to our raffles, the RNS will be giving away a select number of grand prizes. Raffles are chosen at random while grand prizes will be given away to those who qualify in the following areas: Highest Engagement Overall, Most Educational Questions Asked, and the “Find Elvis” Raffle. Grand prize winners will be announced during the Farewell Reception at the end of the event. Winners must be present during the reception to claim a prize. Additional details on how to play and qualify will be provided during the live event broadcast. See also, Terms & Conditions listed below.
Referral Contest In order for the entry to count, your referral must (a) include your first and last name in the referral field on their registration form, and (b) complete the evaluation at the end of the event or OnDemand portion of the event. Winner will be contacted via email by May 30, 2021.
Terms & Conditions
You must be 18 years or older to claim a prize.
You must be registered and attend the event to win (NOTE: OnDemand participants who did not attend the live event are still eligible to win the referral contest).
Winners must verify their shipping address by contacting events@rnsnurse.org before prizes will be distributed
Session Description
Transitioning your Lupus Patient from Pediatric to Adult Care
Transfer of care from pediatrics to adults can be difficult for patients, especially for patients diagnosed with lupus, a disease with a high rate of comorbidity. In this session, we will address comorbid manifestations in lupus, and how to best prepare our patients for their transition to adult providers.
Session Description
Pregnancy and Women’s Health in Psoriatic Arthritis (PsA)
In this session you will learn about how Psoriatic Arthritis (PsA) impacts your pregnant patients and the latest American College of Rheumatology guidelines.
Session Description
Treating Interstitial Lung Disease (ILD) in Sarcoidosis
Interstitial lung disease (ILD), sarcoidosis is lesser known in the specialty of rheumatology and requires a multidisciplinary approach to treatment. This session will provide the pathophysiology and disease process in interstitial lung disease, as well as treatment and support considerations in interstitial lung disease patients with sarcoidosis.
Session Description
An Integrative and Alternative Approach to Rheumatology Patient Care
In this session, we will take a look at an integrative approach to patient care, combining complementary and alternative treatments in addition to medical therapies commonly applied in rheumatology.
Session Description
An Overview of Vasculitis for the Nurse and Advanced Practice Provider
Vasculitis can range from mild to life threatening symptoms, so it is important as providers to know where your patient falls on the spectrum. This session will cover a global overarching review of the disease, including detection, manifestations, and treatments.
Session Description
What Antiphospholipid Syndrome (APS) Looks Like in the Rheumatology Patient
In this session, we will be walking through diagnosis to care for our patients with antiphospholipid syndrome (APS). We will be discussing pathophysiology, immunology, differential diagnosis, clinical presentation, and treatment of antiphospholipid syndrome.
Session Description
A Deeper Dive into Spondylitis with You and Your Patient
Though patients may not pay attention to codes that their healthcare providers jot down, nurses and advanced practice providers know just how important that clerical detail can be. In this session, we will break down what the recent ICD-10 classification of non-radiographic axial spondyloarthritis (nr-axSpA) means for you as a provider and the future treatment of non-radiographic axial spondyloarthritis.
Session Description
Updates on Guidelines in Treating Your Gout Patients
Gout is the most common form of inflammatory arthritis seen in rheumatology patients, and the American College of Rheumatology (ACR) released in 2020 new Guidelines for the Management of Gout. In this learning session we will be exploring the these updated treatment guidelines as well as recent and pipeline treatments so we can best serve our patients with the most current research released.
Session Description
Where Are We Now? A Look Back Through COVID-19 as of Fall 2020
It’s been nearly one year since COVID-19 was first identified as an infectious disease. Through the evolution and spread of the disease, we have learned a lot about what works and what we should avoid. In this session, we will talk about the most recent updates to treatment options for patients, particularly those with rheumatic diseases.
Session Description
Differentiating Between Ehlers-Danlos Syndrome and Other Hypermobility Syndromes
Take an assiduous look at the complexities between Ehlers-Danlos syndromes (EDS) and other hypermobility syndrome (HMS) as we discuss clinical manifestations, the diagnostic workup, and what long term outcomes are for the hypermobility syndrome and Ehlers-Danlos syndromes patient.
Session Description
How Genetics Will Impact the Future of Rheumatology
In this session, we will introduce translational genetics and genomics through the lenses of rheumatic diseases, such as Behcet’s Disease, Stills Disease, and Systemic Onset Juvenial Idiopathic Arthritis (SoJIA).
Session Description
Immunology in Rheumatoid Arthritis
In this session, we will discuss the application of the fundamentals of immunology in patients with rheumatoid arthritis.
Session Description
Understanding Thyroid Eye Disease and How it Relates to Rheumatology
Thyroid eye disease is often linked with other comorbidities, including many autoimmune diseases. In this session, learn how thyroid eye disease presents itself in patients with other rheumatic conditions.
Session Description
Of Mice and Men: DMOAD Therapy for the Osteoarthritic Knee
This session will focus on the common findings, challenges, and targets of therapy including the use of disease modifying osteoarthrits drugs (DMOADS) in patients with osteoarthritic knees.
Sorry
Our individual sessions are not yet available for registration
We will be getting this registration up and running in the next couple of days.
Please check back soon!
Session Description
An Overview of Interstitial Lung Disease (ILD), Ehler's Danlos Syndrome (EDS), and Polymyalgia Rheumatica (PMR)
A rapid fire approach to understanding Interstitial Lung Disease (ILD), Ehler’s Danlos Syndrome (EDS), and Polymyalgia Rheumatica (PMR).
Session Description
An Overview of Vasculitis for the Nurse and Advanced Practice Provider
Vasculitis can range from mild to life threatening symptoms, so it is important as providers to know where your patient falls on the spectrum. This session will cover a global overarching review of the disease, including detection, manifestations, and treatments.
Session Description
The Role and Impact of Infusible Therapies on Your Practice
In this session, learners will develop an understanding of the role and impact of infusion therapies and it’s impact in clinical rheumatology practice.
Session Description
The Progression of Lupus and Research
In this session, we will explore the history and progression of lupus and research in systemic lupus erythematosus (SLE) and lupus nephritis (LN).
Session Description
Pregnancy and Women's Health in Rheumatoid Arthritis (RA)
Rheumatoid arthritis (RA) presents differently throughout a woman’s journey into motherhood. From disease activity improvements to flare ups, learn what rheumatoid arthritis looks like from conception to post-partum, and how best to support mothers throughout the process.
Session Description
An Interdisciplinary Approach to Rheumatic Diseases
In this panel presentation, you will hear from multiple specialities regarding the best practices on treating rheumatic diseases.
Session Description
Navigating the COVID-19 Vaccines with Your Patients
The COVID-19 pandemic has forced healthcare providers to learn and adapt in an unprecedented environment, including accommodating our patients with the new vaccines on the market. In this session, we will discuss what the vaccine means for our practices, and how it could affect those with rheumatologic and other autoimmune diseases.
Session Description
Clinical Perspectives of Psoriatic Arthritis (PsA) Through the Eyes of Dermatology and Rheumatology
Psoriatic Arthritis (PsA) is one of the most common rheumatologic diseases we see in patients, and dermatologists are in a unique position to recognize early signs of PsA. In this co-presentation, we will hear from both a rheumatology and dermatology provider in recognizing these signs, and how the two practices can work together to provide the best patient care.